Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences
Part of paid clinical trials in San Diego, California.
- Sponsor
- San Diego State University
- Study ID
- NCT05007561
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Naltrexone
- Placebo
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 25 Years
- Healthy Volunteers
- Accepted
Interventions
- Naltrexone Hydrochloride — DRUGoral naltrexone
- Placebo — DRUGoral sugar pill
Study Details
The study is a randomized, placebo-controlled design with the opioid antagonist, oral naltrexone. Following random assignment, participants will take 50mg of naltrexone or placebo once a day for 7 days. On days 1 - 7, participants complete reports of their feelings of social connection and mood in order to assess more naturalistic feelings in response to opportunities for social connection outside of the laboratory setting. Additionally, at the end of each day, they complete a physical symptoms questionnaire. On the 7th day, participants will come to the SDSU MRI scanning facility to complete tasks designed to elicit feelings of social connection in the fMRI scanner. After the scan, feelings in response to the scanner tasks will be collected.
Key Dates
- Start date
- Nov 16, 2021
- Status verified
- Apr 2026
- Primary completion
- Apr 30, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 210 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Naltrexone50mg naltrexone HCL once daily for seven days by mouth
- Placebo Comparator: placebosugar pill once daily for seven days by mouth
Primary Outcome Measure
Daily feelings of social connection via ecological momentary assessment [ Time Frame: post-treatment, change across 7 days ]
Central Contacts
- Tristen Inagaki, PhD6195941058
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| San Diego State University | San Diego | California | 92120 | Tristen Inagaki, PhD |
Find similar trials in San Diego, CA
Related Studies
- Suvorexant as an Adjunct to Buprenorphine in Persons Who Use FentanylPHASE2 · Recruiting · Johns Hopkins University · Baltimore, Maryland
- Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)Recruiting · University of Maryland, Baltimore · Baltimore, Maryland